Page last updated: 2024-08-25

rosiglitazone and Leukemia, Promyelocytic, Acute

rosiglitazone has been researched along with Leukemia, Promyelocytic, Acute in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, J; Huang, F; Li, Y; Zhang, XK; Zhou, H1

Other Studies

1 other study(ies) available for rosiglitazone and Leukemia, Promyelocytic, Acute

ArticleYear
Rosiglitazone binds to RXRα to induce RXRα tetramerization and NB4 cell differentiation.
    Biochemical and biophysical research communications, 2020, 09-10, Volume: 530, Issue:1

    Topics: Cell Differentiation; Cell Line, Tumor; Cell Proliferation; HEK293 Cells; Humans; Hypoglycemic Agents; Leukemia, Promyelocytic, Acute; Protein Multimerization; Retinoid X Receptor alpha; Rosiglitazone

2020